(TOP (S (NP (NNP REPLIGEN) (NNP Inc.)) (VP (VBD said) (SBAR (S (NP (PRP it)) (VP (MD will) (VP (VB issue) (NP (QP (CD one) (CD million)) (JJ new) (JJ common) (NNS shares)) (PP (IN in) (NP (DT a) (ADJP (QP (money ($ $) (CD 9) (CD million)))) (JJ private) (NN placement))) (PP (TO to) (NP (NP (JJ institutional) (NNS investors)) (PP (IN in) (NP (DT the) (NNP U.K)))))))))) (. .)) )
(TOP (S (NP (DT The) (NAC (location (NNP Cambridge)) (, ,) (NNP Mass.) (, ,)) (NN biotechnology) (NN company)) (VP (VBD said) (SBAR (S (NP (NNS proceeds)) (VP (MD will) (VP (AUX be) (VP (VBN used) (S (VP (TO to) (VP (VB broaden) (NP (NP (PRP$ its) (NN research) (CC and) (NN development)) (PP (IN of) (NP (NNS products)))) (S (VP (VP (TO to) (VP (VB fight) (NP (JJ infectious) (NNS diseases)))) (CC and) (VP (TO to) (VP (VB increase) (NP (NN manufacturing) (NNS capabilities))))))))))))))) (. .)) )
(TOP (S (S (NP (organization (NNP Bear) (NNP Stearns) (CC &) (NNP Co.))) (VP (VBD handled) (NP (NP (DT the) (NN closing)) (PP (IN of) (NP (DT the) (NNS transactions)))))) (, ,) (NP (person (NNP Repligen))) (VP (VBD said)) (. .)) )
(TOP (S (PP (IN After) (NP (DT the) (NN sale))) (, ,) (NP (person (NNP Repligen))) (VP (MD will) (VP (AUX have) (NP (NP (QP (RB about) (CD 8.3) (CD million)) (NNS shares)) (ADJP (JJ outstanding))))) (. .)) )
